Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

adminDecember 20, 202401 mins

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Related News

Opawica Announces the Closing of Non-Brokered Private Placement

December 22, 2024

Silver Price Forecast: Top Trends That Will Affect Silver in 2025

December 21, 2024

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

December 20, 2024

Back To Top